NDC properties for NDC 9 0115-2611
NDC item 00115261101
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-01 |
| NDC Item | 00115261101 |
| packaging | 100 TABLET in 1 BOTTLE (0115-2611-01) |
| ANDA | ANDA075877 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 815273 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
NDC item 00115261102
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-02 |
| NDC Item | 00115261102 |
| packaging | 500 TABLET in 1 BOTTLE (0115-2611-02) |
| ANDA | ANDA075877 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 815273 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
NDC item 00115261103
| NDC 9 | 0115-2611 |
|---|---|
| NDC 10 | 0115-2611-03 |
| NDC Item | 00115261103 |
| packaging | 1000 TABLET in 1 BOTTLE (0115-2611-03) |
| ANDA | ANDA075877 |
| COLORTEXT | white(off-white) |
| Color | C48325 __ |
| FDA SPL set id | 815273 |
| Imprint code | G;2611 |
| Labeler | Amneal Pharmaceuticals of New York LLC |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2001-06-26 |
| Marketing status | ACTIVE |
| Score | 1 |
| Shapetext | convex |
| Shape | C48345 |
| Size | 11 mm |
NDC item 00527131801
| NDC 9 | 0527-1318 |
|---|---|
| NDC 10 | 0527-1318-01 |
| NDC Item | 00527131801 |
| packaging | 100 TABLET in 1 BOTTLE (0527-1318-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 521990 |
| Imprint code | LCI;1318 |
| Labeler | Lannett Company, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
NDC item 10135057901
| NDC 9 | 10135-579 |
|---|---|
| NDC 10 | 10135-579-01 |
| NDC Item | 10135057901 |
| packaging | 100 TABLET in 1 BOTTLE (10135-579-01) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 441971 |
| Imprint code | LCI;1318 |
| Labeler | Marlex Pharmaceuticals Inc |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2014-10-01 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
NDC item 24979013201
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-01 |
| NDC Item | 24979013201 |
| packaging | 100 TABLET in 1 BOTTLE (24979-132-01) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
NDC item 24979013203
| NDC 9 | 24979-132 |
|---|---|
| NDC 10 | 24979-132-03 |
| NDC Item | 24979013203 |
| packaging | 1000 TABLET in 1 BOTTLE (24979-132-03) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 750481 |
| Imprint code | T132 |
| Labeler | TWi Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
NDC item 62135052490
| NDC 9 | 62135-524 |
|---|---|
| NDC 10 | 62135-524-90 |
| NDC Item | 62135052490 |
| packaging | 90 TABLET in 1 BOTTLE (62135-524-90) |
| ANDA | ANDA077152 |
| COLORTEXT | white |
| Color | C48325 __ |
| FDA SPL set id | 698324 |
| Imprint code | LCI;1318 |
| Labeler | Chartwell RX, LLC. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2005-03-25 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
NDC item 62559072101
| NDC 9 | 62559-721 |
|---|---|
| NDC 10 | 62559-721-01 |
| NDC Item | 62559072101 |
| packaging | 100 TABLET in 1 BOTTLE (62559-721-01) |
| COLORTEXT | WHITE(White to faintly yellow) |
| Color | C48325 __ |
| FDA SPL set id | 424433 |
| Imprint code | ANI;721 |
| Labeler | ANI Pharmaceuticals, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA AUTHORIZED GENERIC |
| Marketing effective time low | 2018-10-16 |
| Marketing status | ACTIVE |
| NDA_AUTHORIZED_GENERIC | NDA017849 |
| Score | 2 |
| Shape | C48345 |
| Size | 11 mm |
NDC item 68084025611
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-11 |
| NDC Item | 68084025611 |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
NDC item 68084025621
| NDC 9 | 68084-256 |
|---|---|
| NDC 10 | 68084-256-21 |
| NDC Item | 68084025621 |
| packaging | 30 BLISTER PACK in 1 CARTON (68084-256-21) / 1 TABLET in 1 BLISTER PACK (68084-256-11) |
| ANDA | ANDA077152 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 101428 |
| Imprint code | LCI;1318 |
| Labeler | American Health Packaging |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time high | 2015-08-31 |
| Marketing effective time low | 2008-03-26 |
| Marketing status | COMPLETED |
| Score | 2 |
| Shape | C48348 |
| Size | 7 mm |
NDC item 71205093800
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-00 |
| NDC Item | 71205093800 |
| packaging | 100 TABLET in 1 BOTTLE (71205-938-00) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
NDC item 71205093830
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-30 |
| NDC Item | 71205093830 |
| packaging | 30 TABLET in 1 BOTTLE (71205-938-30) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
NDC item 71205093855
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-55 |
| NDC Item | 71205093855 |
| packaging | 500 TABLET in 1 BOTTLE (71205-938-55) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
NDC item 71205093860
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-60 |
| NDC Item | 71205093860 |
| packaging | 60 TABLET in 1 BOTTLE (71205-938-60) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |
NDC item 71205093890
| NDC 9 | 71205-938 |
|---|---|
| NDC 10 | 71205-938-90 |
| NDC Item | 71205093890 |
| packaging | 90 TABLET in 1 BOTTLE (71205-938-90) |
| ANDA | ANDA211832 |
| COLORTEXT | WHITE |
| Color | C48325 __ |
| FDA SPL set id | 635034 |
| Imprint code | T132 |
| Labeler | Proficient Rx LP |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Marketing effective time low | 2020-07-13 |
| Marketing status | ACTIVE |
| Score | 2 |
| Shape | C48345 |
| Size | 9 mm |